Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-031200

Director bought 500 shares at $19.12 ($9,560)

From the SEC's structured data for this filing

Trades in this filing

Powell Andrew Kenneth William · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-16 Purchase : show line 1 in the form +500 $19.12 $9,560 500 D
Open-market purchases · 500 sh · avg $19.12 · $9,560
Loading xslF345X03/doc4.xml…